Clinical Trial Update: High-dose Dexamethasone Versus Conventional Dose Prednisone for Initial Treatment of Primary Immune Thrombocytopenia (ITP) [Phase 4]

View source ↗

Summary

Phase 4 trial comparing high-dose dexamethasone to conventional-dose prednisone for initial treatment of primary immune thrombocytopenia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Idiopathic Thrombocytopenic Purpura
• Immune Thrombocytopenia

Drugs mentioned

• DEXAMETHASONE (Dexamethasone)
• PREDNISONE (Prednisone)

Snippet

Sponsor: Shandong University | Conditions: Purpura, Thrombocytopenic, Idiopathic | Phase 4 | Status: COMPLETED